Who is global blood therapeutics? Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities.Is global blood therapeutics sickle cell treatment approved by the fda? Global Blood Therapeutics Inc said on Tuesday the U.S. Food and Drug Administration had granted priority review for two applications related to its treatment for sickle cell disease in children.What is global blood therapeuticss iss governance quality score? Global Blood Therapeutics, Inc.’s ISS Governance QualityScore as of July 1, 2021 is 10. The pillar scores are Audit: 3; Board: 9; Shareholder Rights: 8; Compensation: 10.
Global Blood Therapeutics, Inc. is a Delaware Corporation filed On February 4, 2011. The company's File Number is listed as 4936182. The Registered Agent on file for this company is The Corporation Trust Company and is located at Corporation Trust Center 1209 Orange St, Wilmington, DE 19801.